Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Speciality Molecules Limited, was an unlisted public company incorporated on 29 January, 1998. It is classified as a public limited company and is located in , Uttar Pradesh. It's authorized share capital was INR 10.00 cr and the total paid-up capital was INR 58.00 lac.
The current status of Speciality Molecules Limited is - Amalgamated.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Shyam Nath Singh | 00010530 | 17 years |
Director | Rajagopal Sankaraiah | 00025022 | 17 years |
Director | Rajesh Kumar Srivastava | 02215055 | 17 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
FIRST TRUST MEDICARE PRIVATE LIMITED |
Amalgamated
|
10.0 L | 1 | Uttar Pradesh |
JUBILANT INNOVATION (INDIA) LIMITED |
Dissolved
|
5.0 L | 1 | Uttar Pradesh |
BAXY ENGINEERING PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Delhi |
BAXY MOBILITY PRIVATE LIMITED |
Active
|
1.6 Cr | 1 | Delhi |
STRAFIN SOLUTIONS LLP |
Active
|
1.0 L | 1 | Haryana |
BAXY LIMITED |
Active
|
9.8 Cr | 1 | Delhi |
JUBILANT CHEMSYS LIMITED |
Amalgamated
|
8.2 Cr | 1 | Uttar Pradesh |
JUBILANT BHARTIA FOUNDATION |
Active
|
7,000.0 | 1 | Uttar Pradesh |
SAJJAN INDIA LIMITED |
Active
|
3.6 Cr | 1 | Maharashtra |
Read more
The incorporation date of SPECIALITY MOLECULES LIMITED is 29 January, 1998
The authorized share capital of SPECIALITY MOLECULES LIMITED is INR ₹ 10.0 Cr.
The paid-up capital of SPECIALITY MOLECULES LIMITED is INR ₹ 58.0 L.
The registered address of SPECIALITY MOLECULES LIMITED is BHARTIAGRAM GAJRAULA Jyotiba Phule Nagar Uttar Pradesh - 244223
The CIN number of SPECIALITY MOLECULES LIMITED is U24119UP1998PLC037398.